Oncorena

Oncorena Holding AB

This pharmaceutical company develops a synthetic orellanine therapy for patients with metastatic renal cancer.

River Renal

This clinical-stage biotechnology company develops novel pharmaceutical therapies targeting orphan renal diseases for patients with unmet medical needs.

CINC

This company develops biopharmaceutical treatments for cardio-renal diseases, primarily for patients with hypertension and chronic kidney disease.

Chromacure

This company develops small molecule therapeutics for oncology patients to address unmet clinical needs in cancer treatment.

Oncko

This company develops multi-drug cancer therapies and clinical platform trials to identify optimal treatment combinations and schedules for pharmaceutical partners and patients.

Roca Therapeutics

The company develops small molecule therapies for patients with severe ocular diseases and cancers such as uveal melanoma.

Peloton Therapeutics

This biopharmaceutical company develops small molecule oral medicines for patients with renal cell carcinoma and other forms of cancer.

Full-Life Technologies

This company develops radiopharmaceuticals and radionuclide drug conjugates to treat cancer patients through targeted alpha therapy.